PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
6.53%
Similar revenue growth to VET's 6.58%. Walter Schloss would investigate if similar growth reflects similar quality.
26.53%
Cost growth 50-75% of VET's 46.08%. Bruce Berkowitz would examine sustainable cost advantages.
-16.61%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-21.72%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
-6.04%
G&A reduction while VET shows 1.32% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-4750.00%
Other expenses reduction while VET shows 133.87% growth. Joel Greenblatt would examine efficiency.
-76.22%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-9.30%
Total costs reduction while VET shows 24.13% growth. Joel Greenblatt would examine advantage.
7.14%
Interest expense growth 50-75% of VET's 13.31%. Bruce Berkowitz would examine efficiency.
14.26%
D&A growth less than half of VET's 62.71%. David Dodd would verify if efficiency is sustainable.
76.12%
EBITDA growth exceeding 1.5x VET's 5.31%. David Dodd would verify competitive advantages.
38.00%
EBITDA margin growth exceeding 1.5x VET's 14.77%. David Dodd would verify competitive advantages.
80.51%
Operating income growth while VET declines. John Neff would investigate advantages.
69.45%
Operating margin growth while VET declines. John Neff would investigate advantages.
-63.51%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
171.50%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
154.86%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
1723.08%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
110.84%
Net income growth while VET declines. John Neff would investigate advantages.
97.91%
Net margin growth while VET declines. John Neff would investigate advantages.
112.16%
EPS growth while VET declines. John Neff would investigate advantages.
111.56%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-0.51%
Both companies reducing share counts. Martin Whitman would check patterns.
-0.33%
Both companies reducing diluted shares. Martin Whitman would check patterns.